Despite incomplete evidence, longevity enthusiasts are experimenting with SGLT2 inhibitors in their quest to live healthier for longer.
Alex Janin is a Reporter at various esteemed publications, including The Wall Street Journal and Yahoo Finance. He covers a range of topics with a focus on finance, business, and economic trends, providing insightful analysis and reporting on current events. Alex's work has also been featured in The Epoch Times, LiveMint, Yahoo News, Magzter, and MSN.





